LAWRENCE, Mass., Aug. 28, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the U.S. Food and Drug Administration (FDA) has cleared its System One for solo home hemodialysis, without a care partner, during waking hours.
http://ir.nxstage.com/releasedetail.cfm?ReleaseID=1038360This is good news for me (and many others), even though I haven't started yet, this is what I want ultimately. (Other than a transplant!)